Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Market Cap | 202.562 Million | Shares Outstanding | 37.511 Million | Avg 30-day Volume | 67.799 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.5 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -76.539 Million |
Price to Book Value | 1.1679 | Operating Margin | 0.0 | Enterprise Value | 45.477 Million |
Current Ratio | 10.488 | EPS Growth | 0.988 | Quick Ratio | 10.009 |
1 Yr BETA | 1.3506 | 52-week High/Low | 18.52 / 3.83 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -55.4643 | Altman Z-Score | 2.29 | Free Cash Flow to Firm | -62.872 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
16,911 | 2022-06-14 | 1 | |
|
16,911 | 2022-06-14 | 1 | |
|
16,911 | 2022-06-14 | 1 | |
|
16,911 | 2022-06-14 | 1 | |
|
16,911 | 2022-06-14 | 2 | |
|
16,911 | 2022-06-14 | 1 | |
|
16,911 | 2022-06-14 | 1 | |
ANG ROBERT PRESIDENT AND CEO |
|
376,000 | 2022-02-01 | 1 |
CHAKRABORTY TIRTHA CHIEF SCIENTIFIC OFFICER |
|
101,000 | 2022-02-01 | 2 |
SLAPAK CHRISTOPHER CHIEF MEDICAL OFFICER |
|
116,000 | 2022-02-01 | 1 |
JORGENSEN NATHAN D. CHIEF FINANCIAL OFFICER |
|
135,000 | 2022-02-01 | 1 |
|
6,361,723 | 2021-11-16 | 1 | |
|
No longer subject to file | 2021-02-09 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
VOR BIOPHARMA INC VOR | 2022-08-15 22:15:04 UTC | -0.7502 | 3.0702 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 21:45:04 UTC | -0.7502 | 3.0702 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 21:15:04 UTC | -0.7502 | 3.0702 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 20:45:04 UTC | -0.7979 | 3.1179 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 20:15:03 UTC | -0.7979 | 3.1179 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 19:45:04 UTC | -0.7979 | 3.1179 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 19:15:04 UTC | -0.7979 | 3.1179 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 18:45:04 UTC | -0.7979 | 3.1179 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 18:15:04 UTC | -0.7979 | 3.1179 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 17:45:04 UTC | -0.7979 | 3.1179 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 17:15:03 UTC | -0.7979 | 3.1179 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 16:45:04 UTC | -0.8507 | 3.1707 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 16:15:04 UTC | -0.8507 | 3.1707 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 15:45:04 UTC | -0.8507 | 3.1707 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 15:15:04 UTC | -0.8507 | 3.1707 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 14:45:04 UTC | -0.8507 | 3.1707 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 14:15:03 UTC | -0.8507 | 3.1707 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 13:45:04 UTC | -1.1763 | 3.4963 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 13:15:04 UTC | -1.1763 | 3.4963 | 40000 |
VOR BIOPHARMA INC VOR | 2022-08-15 12:45:04 UTC | -1.1763 | 3.4963 | 40000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | VOR | -1600.0 shares, $-9664.0 | 2022-03-31 | N-PORT |